Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) (Novartis CSTI571BUS282) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Queens Cancer Center of Queens Regional Hospital |
Principal Investigator: |
Margaret Kemeny, MD |
|---|---|
Contact: |
Linda Bulone 718-883-3751 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Queens Cancer Center of Queens Regional Hospital Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.